Contraceptive Drugs and Devices Market (By Product: Contraceptive Drugs, Contraceptive Pills, Patch, Injectable, Contraceptive Devices) - Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2024-2033

Contraceptive Drugs and Devices Market Size and Forecast 

The global contraceptive drugs and devices market size was estimated at around USD 29.62 billion in 2023 and it is projected to hit around USD 52.7 billion by 2033, growing at a CAGR of 5.93% from 2024 to 2033. The contraceptive drugs and devices market encompasses a wide range of products aimed at preventing unintended pregnancies and reducing the spread of sexually transmitted infections (STIs). This market includes both contraceptive drugs, such as oral pills, patches, injectables, and emergency contraception, as well as contraceptive devices, including intrauterine devices (IUDs), condoms, vaginal rings, diaphragms, and subdermal implants. Increasing awareness about reproductive health, government initiatives promoting family planning, and advancements in contraceptive technologies are driving the growth of this market

Key Pointers

• Asia Pacific dominated the global contraceptive drugs and devices market with the largest market of 34% in 2023.
• By Product, the contraceptive devices segment captured the maximum market share of 69% in 2023.
• By Product, the contraceptive drugs are estimated to expand the fastest CAGR of 3.53% from 2024 to 2033.

What are the Growth Factors of Contraceptive Drugs and Devices Market?

The growth of the contraceptive drugs and devices market is driven by an including the rising awareness of family planning and reproductive health. Government initiatives promoting the use of contraceptives, coupled with the increasing global population, have significantly contributed to the demand for these products. Additionally, advancements in contraceptive technologies, such as the development of long-acting reversible contraceptives (LARCs), offer more effective and convenient options for users. The growing prevalence of sexually transmitted infections (STIs) has also spurred the adoption of barrier contraceptives. Furthermore, increasing access to healthcare services, particularly in developing regions, and a shift in societal attitudes toward contraception are key drivers in this market.

What are the Trends in Contraceptive Drugs and Devices Market?

• Rising Awareness of Family Planning: Increased efforts by governments and healthcare organizations to raise awareness about family planning have boosted the demand for contraceptive products.
• Advancements in Contraceptive Technologies: Continuous innovations, including the introduction of long-acting reversible contraceptives (LARCs), offer more efficient and convenient options for consumers.
• Government Initiatives and Support: Favorable government policies and programs promoting the use of contraceptives contribute to market growth, particularly in developing regions.
• Growing Global Population: The need for effective contraception is amplified by the steady increase in the global population, driving the adoption of various contraceptive methods.

What are the Key Challenges Faced by Contraceptive Drugs and Devices Market?

• Cultural and Religious Opposition: In certain regions, cultural and religious beliefs can create significant resistance to the adoption of contraceptives, limiting market growth.
• Side Effects and Health Risks: Some contraceptive methods, particularly hormonal options, are associated with side effects such as weight gain, mood changes, and increased risk of certain health conditions, deterring potential users.
• Lack of Awareness in Low-Income Areas: Limited access to education and healthcare in low-income regions results in low awareness of contraceptive options, posing a challenge to market expansion.
• Cost and Accessibility: High costs of modern contraceptive drugs and devices, particularly in underdeveloped regions, restrict their widespread adoption.

Which Region Dominates the Contraceptive Drugs and Devices Market?

In 2023, Asia Pacific led the contraceptive drugs and devices market with a 34% share. This growth was largely due to government initiatives aimed at increasing awareness about STDs and unwanted pregnancies. Public health programs have also enhanced the availability of contraceptive measures through government-funded medical institutions. The region’s urban population is increasingly focusing on family planning, driven by concerns over population growth and the spread of STDs, which has boosted sales of contraceptive drugs and devices.

What is the Contribution of Asia Pacific to Contraceptive Drugs and Devices Market?

North America Contraceptive Drugs and Devices Market Trends

North America held a 31% share of the global contraceptive drugs and devices market in 2023. This growth was primarily driven by the rising population and the increasing prevalence of STDs and unwanted pregnancies in the region. Urban populations in North America are more inclined to use contraceptive measures to reduce instances of unplanned pregnancies, abortion, and the spread of STDs. Additionally, the region’s advanced healthcare infrastructure, along with supportive government initiatives, has positively impacted market growth.

Europe Contraceptive Drugs and Devices Market Trends

The contraceptive drugs and devices market in Europe has emerged as a lucrative region, benefiting from a developed healthcare infrastructure and growing awareness about contraception. The region’s urban population is increasingly utilizing contraceptive options such as IUDs, condoms, and other methods, reflecting a heightened focus on sexual health and family planning. These trends, combined with strong healthcare systems, are fostering growth in the European contraceptive market.

Product Insights

In 2023, the contraceptive devices segment led the market, accounting for 69% of the total share. This segment is further categorized into intrauterine devices (IUDs), condoms, vaginal rings, subdermal implants, and diaphragms. The growth of this segment can be attributed to increasing awareness of contraceptive options, largely due to active government and public welfare initiatives aimed at preventing unwanted pregnancies. Contraceptive devices are also highly effective in preventing the spread of sexually transmitted diseases (STDs) and in avoiding unplanned pregnancies. Furthermore, leading industry players are heavily investing in the development of innovative contraceptive devices, further driving market expansion.

Contraceptive drugs are projected to grow at a compound annual growth rate (CAGR) of 3.53% during the forecast period. This growth is driven by increasing awareness around the prevention of unwanted pregnancies and the availability of contraceptive methods such as pills, patches, and injectables. The rising accessibility of these products and their growing acceptance, particularly among urban populations, are key factors propelling this segment, as more individuals prioritize sexual health and family planning.

Who are the Top Manufactures in Contraceptive Drugs and Devices Market?

• Abbvie, Inc.
• Afaxys, Inc.
• Agile Therapeutics
• Bayer AG
• China Resources (Holdings) Co., Ltd.
• Church & Dwight Co., Inc.
• Cupid Limited
• Helm AG
• Johnson & Johnson Services, Inc.
• Organon Group of Companies
• Pfizer Inc.
• Veru, Inc.
• Viatris Inc.

Contraceptive Drugs and Devices Market Segmentation:

By Product 

• Contraceptive Drugs
  • Contraceptive Pills
  • Patch
  • Injectable
• Contraceptive Devices
  • Condoms
    • Male Condoms
    • Female Condoms
  • Subdermal Implants
  • Intrauterine Devices (IUDs)
    • Copper IUDs
    • Hormonal IUDs
• Vaginal Ring
• Diaphragm

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa (MEA)